Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.145 BRL
223.62 M BRL
5.49 B BRL
253.38 M
About ONCOCLINICASON NM
Sector
Industry
CEO
Bruno Lemos Ferrari
Website
Headquarters
São Paulo
Founded
2010
ISIN
BRONCOACNOR6
FIGI
BBG011YXP7P6
Oncoclínicas do Brasil Serviços Médicos SA operates as a holding company, which engages in oncology clinics through the health care segment. Its clinics offer treatment services to cancer patients. Its services include chemotherapy, radiotherapy, surgery, hormone therapy, molecular target drugs, immunotherapy, and bone marrow transplant. It also offers special care services such as ensuring of healthy eating, oral health, heart care, and physical activities engagement. It also provides emotional health support and care. The company was founded by Bruno Lemos Ferrari on January 10, 2010 and is headquartered in Sao Paulo, Brazil.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ONCO3 is 3.690 BRL — it has increased by 0.82% in the past 24 hours. Watch ONCOCLINICASON NM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMFBOVESPA exchange ONCOCLINICASON NM stocks are traded under the ticker ONCO3.
ONCO3 stock has fallen by −16.89% compared to the previous week, the month change is a −23.44% fall, over the last year ONCOCLINICASON NM has showed a −61.84% decrease.
We've gathered analysts' opinions on ONCOCLINICASON NM future price: according to them, ONCO3 price has a max estimate of 13.00 BRL and a min estimate of 5.70 BRL. Watch ONCO3 chart and read a more detailed ONCOCLINICASON NM stock forecast: see what analysts think of ONCOCLINICASON NM and suggest that you do with its stocks.
ONCO3 reached its all-time high on Aug 10, 2021 with the price of 19.620 BRL, and its all-time low was 3.940 BRL and was reached on Nov 13, 2024. View more price dynamics on ONCO3 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ONCO3 stock is 7.61% volatile and has beta coefficient of 1.67. Track ONCOCLINICASON NM stock price on the chart and check out the list of the most volatile stocks — is ONCOCLINICASON NM there?
Today ONCOCLINICASON NM has the market capitalization of 2.33 B, it has decreased by −1.11% over the last week.
Yes, you can track ONCOCLINICASON NM financials in yearly and quarterly reports right on TradingView.
ONCOCLINICASON NM is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
ONCO3 earnings for the last quarter are 0.09 BRL per share, whereas the estimation was 0.07 BRL resulting in a 24.58% surprise. The estimated earnings for the next quarter are 0.09 BRL per share. See more details about ONCOCLINICASON NM earnings.
ONCOCLINICASON NM revenue for the last quarter amounts to 1.63 B BRL, despite the estimated figure of 1.63 B BRL. In the next quarter, revenue is expected to reach 1.67 B BRL.
ONCO3 net income for the last quarter is −15.94 M BRL, while the quarter before that showed 3.30 M BRL of net income which accounts for −582.74% change. Track more ONCOCLINICASON NM financial stats to get the full picture.
No, ONCO3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONCOCLINICASON NM EBITDA is 1.03 B BRL, and current EBITDA margin is 18.47%. See more stats in ONCOCLINICASON NM financial statements.
Like other stocks, ONCO3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOCLINICASON NM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONCOCLINICASON NM technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONCOCLINICASON NM stock shows the sell signal. See more of ONCOCLINICASON NM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.